Xconomy Boston

Predictive BioSciences Lands $21,750,000 Series B Financing

  • Feed Type
  • Date
    10/16/2008
  • Company Name
    Predictive BioSciences
  • Mailing Address
    128 Spring Street, 400 Level, B Annex Lexington, MA 02421
  • Company Description
    Predictive Biosciences is a molecular diagnostics company headquartered in Lexington, MA. Launched in 2006 with a $10 million Series A financing, the company was jointly founded by leading healthcare investors, experienced entrepreneurs, and internationally-renowned scientists in the areas of tumor growth, tumor angiogenesis, and cancer markers. Predictive Biosciences possesses an extensive IP portfolio – including 18 issued US patents – and deep in-house expertise in proteomics, diagnostics, oncology, and tumor biomarkers.
  • Website
    http://www.predictivebiosci.com
  • Transaction Type
    Venture Equity
  • Transaction Amount
    $21,750,000
  • Transaction Round
    Series B
  • Proceeds Purposes
    Predictive intends to use the proceeds from the Series B financing to complete current clinical validation studies and initiate multi-center clinical trials.
  • M&A Terms
  • Venture Investor
    New Enterprise Associates
  • Venture Investor
    Kaiser Permanente Ventures
  • Venture Investor
    Flybridge Capital Partners
  • Venture Investor
    Highland Capital Partners

Add Your Thoughts

You will have 10 minutes to edit your post after you press publish.

Comments may be edited for clarity and length, rejected, or deleted.
By clicking "Publish," you are agreeing to these Terms and Conditions.

    

Business, life sciences, and technology news — covering Boston, Seattle, San Diego, Detroit, San Francisco, New York and beyond.

© 2007-2012, Xconomy, Inc. Xconomy is a registered service mark of Xconomy, Inc. All rights reserved.

Site produced by Andrew Koyfman with design from Rob Hunter.